M. B. Gulcan Et Al. , "Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model," DRUG DESIGN DEVELOPMENT AND THERAPY , pp.4203-4213, 2024
Gulcan, M. B. Et Al. 2024. Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model. DRUG DESIGN DEVELOPMENT AND THERAPY , 4203-4213.
Gulcan, M. B., Demirtas, H., ÖZER, A., YIĞMAN, Z., Dursun, A. D., ARSLAN, M., ... OKTAR, G. L.(2024). Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model. DRUG DESIGN DEVELOPMENT AND THERAPY , 4203-4213.
Gulcan, MEHMET Et Al. "Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model," DRUG DESIGN DEVELOPMENT AND THERAPY , 4203-4213, 2024
Gulcan, MEHMET B. Et Al. "Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model." DRUG DESIGN DEVELOPMENT AND THERAPY , pp.4203-4213, 2024
Gulcan, M. B. Et Al. (2024) . "Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model." DRUG DESIGN DEVELOPMENT AND THERAPY , pp.4203-4213.
@article{article, author={MEHMET BURAK GÜLCAN Et Al. }, title={Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model}, journal={DRUG DESIGN DEVELOPMENT AND THERAPY}, year=2024, pages={4203-4213} }